Sleep Number Honored with American Cancer Society’s 2022 Corporate Partner of the Year Award

In advance of World Cancer Day on February 4, Sleep Number Corporation (Nasdaq: SNBR) today announces it is the proud recipient of the American Cancer Society’s (ACS) 2022 Corporate Partner of the Year Award. The national honor recognizes Sleep Number as a leading supporter in the fight against cancer and its meaningful impact to ACS’s mission.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230201006139/en/

In advance of World Cancer Day, Sleep Number today announces it is the proud recipient of the American Cancer Society’s (ACS) 2022 Corporate Partner of the Year Award. The national honor recognizes Sleep Number as a leading supporter in the fight against cancer and its meaningful impact to ACS’s mission.

Sleep Number and ACS announced a landmark partnership on World Cancer Day 2022 to conduct joint research with the goal of developing the first-ever sleep guidelines for cancer patients and survivors. Over the next five years, ACS will leverage Sleep Number’s proprietary sleep data and sleep expertise in its research to identify the impact of quality sleep on cancer prevention and recovery. Additionally, Sleep Number supports ACS’s Hope Lodges, providing Sleep Number smart beds and other sleep innovations to support patients and caregivers when they need to stay away from home during treatment.

According to Dave Benson, ACS Executive Vice President, North Region, “Sleep Number exemplified what ACS hopes to find in partners. We honor partners that go above and beyond and use every facet of their influence to help support our mission. Working with Sleep Number to develop new data and advance science to be used in the fight against cancer is incredible. We’re extremely grateful for Sleep Number’s partnership.”

“We are honored to partner with the American Cancer Society, and to help end cancer as we know it, for everyone,” said Shelly Ibach, Chair, President and CEO, Sleep Number. “Prior ACS research and guidelines – like those on diet and tobacco – have made an indelible impact on all of our health. Our joint research on sleep and cancer will add to that remarkable body of evidence. If sleep can play even a small part in cancer prevention – or, importantly, enhance the quality of life for a patient, caregiver or survivor – we have truly lived our purpose to improve the health and wellbeing of society.”